AC
Alessandro Colasanti
Principal Investigator
University of Sussex
I'm working on
3 months ago
Neuroimaging biomarkers, neuroinflammation, psychopharmacology, metabolic psychiatry
About
Uses quantitative PET/MRI/MRS to map neuroinflammation and brain metabolism, link immune–metabolic dynamics to mood symptoms, and test pharmacologic and behavioral interventions. Goal: translatable biomarkers that guide clinical trials and enable precision care in neuropsychiatry.
Partnering listings
Learn more
University of Sussex
In vivo assessment of immune-metabolic effects of mitophagy modulators for neuroinflammation
A research platform combining in vitro mitophagy screening with multimodal MRI-based imaging to evaluate mitophagy modulators as therapeutic candidates for neuroinflammation in multiple sclerosis. Leverages expertise in ...
TechnologyConceptualUniversity
University of Sussex
Neuro-metabolic platform for consumer response analysis using fmrs
A neuro-metabolic platform leveraging functional magnetic resonance spectroscopy (fMRS) to quantify implicit consumer responses during product interactions. The platform identifies neurometabolic signatures associated wi...
TechnologyIn developmentUniversity
University of Sussex
Advanced confocal microscopy for imaging mitochondrial health in neurodegeneration
A cutting-edge confocal microscopy technique designed to examine mitochondrial health in live cells, offering insights into mitochondrial dynamics and potential pharmacological interventions for neurodegenerative disease...
TechnologyConceptualUniversity
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.